Stepwise sequential screening for Down's syndrome (combined test associated with modified genetic sonography) in pregnant women with low risk for chromosomal disorders

Journal of Perinatal Medicine

Volumn 40, Issue 6, 2012, Pages 647-651

  Sainz, José A ^a,b   Peral, Ignacio ^a   Borrero, Carlota ^a   Almeida, Carmen ^a   Moro, Antonio ^a   Turmo, Enriqueta ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Combined test; Down's syndrome; Genetic sonography; Modified genetic sonography; Prenatal screening

Indexed keywords

ARTICLE; CHROMOSOME DISORDER; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; GENETIC SCREENING; GENETIC SONOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRISOMY 21; PREGNANCY; PRENATAL DIAGNOSIS;

CHROMOSOME DISORDERS; DOWN SYNDROME; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES;

EID: 84869390671     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2012-0110     Document Type: Article

References (30)

1. Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, et al. Role of second-trimester genetic sonography after Down sndrome screening. Obstet Gynecol. 2009;114: 1189-96.
2. American College of Obstetricians and Gynecologists. Practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109: 217-27.
3. Benacerraf BR. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice. Prenat Diagn. 2010;30: 644-52.
4. Benacerraf BR, Frigoletoo FD Jr. Soft tissue nuchal fold in the second-trimester fetus: standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol. 1987;157: 1146-9. (Pubitemid 17163786)
5. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol. 2002;100: 1168-76. (Pubitemid 35449182)
6. Bromley B, Lieberman E, Shipp T, Benacerraf B. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med. 2002;21: 1087-96.
7. Cuckle H. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol. 2000;92: 97-101.
8. Cuckle H, Benn P, Wright D. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol. 2005;29: 252-7. (Pubitemid 41133566)
9. Kagan KO, Staboulidou I, Cruz J, Wright D, Nicolaides KH. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol. 2010;36: 542-7.
10. Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33: 18-22.
11. Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33: 512-7.
12. Malone FD, Canick JA, Ball RH. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005;353: 2001-11. (Pubitemid 41609093)
13. Mulvey S, Wallace EM. Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. Br J Obstet Gyaecol. 2000;107: 1302-5.
14. Muñoz-Cortes M, Arigita M, Falguera G, Seres A, Guix D, Baldrich E, et al. Contingent screening for Down syndrome completed in the first trimester. Multicenter study. Ultrasound Obstet Gynecol. 2012;39: 396-400.
15. Nicolaides KH. Screening for chromosomal defects. Ultrasound Obstet Gynecol. 2003;21: 313-21. (Pubitemid 36555106)
16. Nicolaides KH, Sebire NJ, Snijders R, editors. The 11-14 week scan. London: The Parthenon Publishing Group; 1999.
17. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first trimester screening. Ultrasound Obstet Gynecol. 2005;25: 221-6. (Pubitemid 40432687)
18. Nyberg D, Luthy D, Resta R, Nyberg B, Willian M. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analy sis of 142 cases. Ultrasound Obstet Gynecol. 1998;12: 8-14. (Pubitemid 28379283)
19. Nyberg D, Souter V, El-Bastawissi A, Young S, Luthhardt F, Luthy D. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med. 2001;20: 1053-63. (Pubitemid 32937496)
20. Palomaki GE, Steinort K, Knight GJ, Haddow JE. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Obstet Gynecol. 2006;107: 367-75.
21. Ultrasound screening for fetal abnormalities. Guidelines 2000. Royal College of Obstetricians and Gynaecologists. Available at: http://www.rcog.org. uk.
22. Rozenberg P, Bussières L, Chevret S, Bernard JP, Malagrida L, Cuckle H, et al. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol. 2006;195: 1379-87. (Pubitemid 44740408)
23. Sahota DS, Leung TY, Chan LW, Law LW, Fung TY, Chen M, et al. Comparison of first trimester contingent screening strategies for Down syndrome. Ultrasound Obstet Gynecol. 2010;35: 286-91.
24. Sainz JA, Serrano R, Turmo E, Almeida C, Caballero V, Garrido R. Contribution of "modified genetic sonography" to the combined test as a screening method for chromosomal abnormalities. J Matern Fetal Neonatal Med. 2012;25:1339-405.
25. Salomon LJ, Chevret S, Bussieres L, Ville Y, Rozenberg P. Down syndrome screening using first-trimester combined tests and contingent use of femur length at routine anomaly scan. Prenat Diagn. 2010;30: 783-9.
26. Senat MV, Bernard JP, Boulvain M, Ville Y. Intra- and interoperator variability in fetal nasal bone assessment at 11-14 weeks of gestation. Ultrasound Obstet Gynecol. 2003;22: 138-41. (Pubitemid 36976379)
27. Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. J Am Med Assoc. 2001;285: 1044-55. (Pubitemid 32176418)
28. Protocolo de la semana 20. Prosego 2012. Spanish Society of Obstetrics and Gynaecology. Available at: http://www.sego.es/secciones/ecografia.
29. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study SURUSS. J Med Screen. 2003;10: 56-104. (Pubitemid 36734906)
30. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn. 2004;24: 762-6. (Pubitemid 39468654)